# Continuous Pre-uterine Wound Infiltration Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean Section

> **NCT02279628** · PHASE4 · UNKNOWN · sponsor: **Central Hospital, Nancy, France** · enrollment: 150 (estimated)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Ropivacaine
- **DRUG:** Morphine

## Key facts

- **NCT ID:** NCT02279628
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-07
- **Primary completion:** 2016-12
- **Final completion:** 2017-06
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2014-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02279628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02279628, "Continuous Pre-uterine Wound Infiltration Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean Section". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02279628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*